21.11.2014 Views

Preventing Childhood Obesity - Evidence Policy and Practice.pdf

Preventing Childhood Obesity - Evidence Policy and Practice.pdf

Preventing Childhood Obesity - Evidence Policy and Practice.pdf

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Chapter 2<br />

trade. There are provisions that allow public health<br />

concerns to “ override ” the desire for more free trade<br />

in the WTO but the drawbacks of relying upon WTO<br />

exemptions include economic disincentives associated<br />

with violation of WTO rules that may prevent States<br />

from giving priority to public health when conflicts<br />

arise, <strong>and</strong> may also impede the negotiation, ratification<br />

<strong>and</strong> implementation of international public<br />

health instruments.<br />

Optimize e ffectiveness (in t erms<br />

of q uality <strong>and</strong> c overage) of<br />

e xisting e fficacious i nterventions<br />

e specially in h ealth s ector<br />

There are a number of efficacious <strong>and</strong> effective interventions<br />

that can prevent or reduce the morbidity<br />

<strong>and</strong> mortality associated with non - communicable<br />

diseases. However, too often, the inverse care law<br />

applies in terms of the coverage of these interventions:<br />

those who need the interventions the most are<br />

the least likely to receive them. Within countries, there<br />

are differences in coverage between the rich <strong>and</strong><br />

poor <strong>and</strong> between urban <strong>and</strong> rural areas. There are<br />

also large differences in access to care between<br />

countries.<br />

Unfortunately, the evidence for what works in<br />

terms of scaling up interventions for non - communicable<br />

diseases is limited. Reviews of relatively successful<br />

non - communicable disease programmes have<br />

highlighted some common features including: routine<br />

patient monitoring; shared decision making between<br />

health professionals <strong>and</strong> patients; self - management<br />

support that allow patients to successfully manage<br />

their symptoms, treatments <strong>and</strong> preventive health<br />

behaviors on a day - to - day basis; <strong>and</strong> community<br />

linkages that allow interventions such as population -<br />

based health promotion <strong>and</strong> disease prevention,<br />

integration of people with NCDs into community life,<br />

<strong>and</strong> provision of complementary <strong>and</strong> home - based<br />

health services. 13 However, nearly all these lessons are<br />

based on non - communicable care models in the USA<br />

or UK with very little evidence of what works at scale<br />

in resource - poor settings. The approach of WHO with<br />

regards to the non - communicable care <strong>and</strong> treatment<br />

of people living with HIV/Aids is interesting in that<br />

it focuses on a slightly different set of principles<br />

(Box 2.2 ).<br />

Box 2.2 Scaling up HIV t reatment<br />

The huge burden of unmet care <strong>and</strong> treatment for HIV<br />

has led to a plethora of treatment options for those<br />

infected, especially in Southern Africa where the epidemic<br />

is at its worst. Difficulty in accessing efficacious<br />

drug treatments has led many HIV patients to spend<br />

significant amounts of resources in accessing sub -<br />

st<strong>and</strong>ard care <strong>and</strong> treatment. Governments <strong>and</strong> agencies<br />

are now responding by scaling up the introduction<br />

of long - term treatment of HIV with the provision of<br />

anti - retroviral treatment ( ART ). The challenges of providing<br />

non - communicable care in the context of weak<br />

health systems have led WHO to adopt what they<br />

termed a “ public - health approach to ART treatment ” .<br />

A number of innovations marked a shift from previous<br />

attempts to provide ART:<br />

1) st<strong>and</strong>ardization of first - line <strong>and</strong> second - line treatment<br />

along with a prescriptive approach, facilitating<br />

the development of fixed - dose first line combinations,<br />

<strong>and</strong> driving down the price of these drugs;<br />

2) simplification of clinical decision making with an<br />

attempt to manage without necessarily having any<br />

immunological monitoring;<br />

3) decentralization of treatment to the district level<br />

through the development <strong>and</strong> training in adapted<br />

integrated management of adult illness (IMAI)<br />

guidelines;<br />

4) task shifting of essential activities such as initiation<br />

<strong>and</strong> monitoring of treatment from physicians to<br />

nurses;<br />

5) procurement <strong>and</strong> supply management strengthening,<br />

with a focus on reducing the number of commodities<br />

<strong>and</strong> drugs <strong>and</strong> being more specific of<br />

exact requirements. Such an approach has allowed<br />

a significant scaling up of the provision of ART <strong>and</strong><br />

early results suggest that while early mortality is<br />

high the medium - term outcomes for those on the<br />

programmes is good. 14<br />

Decentralized c are f ocused at the<br />

p rimary h ealth c are l evel<br />

The example of the scale - up of treatment for HIV/<br />

Aids emphasizes the shift in the care of patients from<br />

specialists <strong>and</strong> hospitals to nurse - led care at a primary<br />

health care center. There is now good evidence from<br />

well resourced settings that primary - care - led patient<br />

models can lead to similar <strong>and</strong> often better outcomes<br />

than specialist, tertiary level care. There is also some<br />

18

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!